Dementia | Page 15 of 20 | SpiritIndia.com

Cancer :: Growth factor signals influence balance between normal growth and cancerous growth – USA

Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis. New research investigates how the growth hormone/IGF system is affected by the important tumor suppressor gene p53. This interplay of two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone, while suggesting a future new avenue for cancer therapy.

Dementia :: New study shows increased risk of dementia before death

As the number of older people increases, the number of people who experience dementia before they die is also likely to increase, according to a new study. The research, spearheaded by Professor Carol Brayne at the University of Cambridge, has shown that factors believed to protect against dementia at earlier stages in life may not provide protection from dementia at the end of life.

Eating Disorders :: Beyond slim – raising awareness of eating disorders

Ulrike Schmidt, Professor in Eating Disorders, will be speaking at the DANA Centre in South Kensington on 14 November 2006 at Beyond Slim, a public event organised jointly by the Institute of Psychiatry and the European Dana Alliance for the Brain. The evening will be chaired by Professor Iain Campbell and will also feature contributions from the Eating Disorders Association and a personal account from someone living with an eating disorder.

Brain Cancer :: Researchers study effects of Aricept in pediatric brain cancer survivors

A pediatric oncologist at Brenner Children’s Hospital is evaluating whether a drug typically used to treat Alzheimer’s patients will help brain cancer survivors avoid the learning and memory problems that are common after radiation therapy.

Eating Disorders :: Beyond slim – raising awareness of eating disorders

Alzheimer’s Disease :: A century of Alzheimer’s is 100 years too many

Today marks a bittersweet anniversary for one Cambridge-based national charity, as the Alzheimer?s Research Trust marks 100 years since the discovery of the disease by the German neurologist Dr Alois Alzheimer.

Dementia :: New dementia screening tool detects early cognitive problems

A screening tool for dementia developed by Saint Louis University geriatricians appears to work better in identifying mild cognitive problems in the elderly than the commonly used Mini Mental Status Examination, according to a new study.

Alzheimer’s Disease :: Therapeutic approaches to Alzheimer’s Disease

Alzheimer’s disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting 5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression.

Alzheimer’s Disease :: Diagnosis before onset of Alzheimer’s disease

Proteins found in the blood can indicate an increased risk of Alzheimer’s disease, according to groundbreaking new research published today (30 October) in the journal Brain. It is the first time markers for the development of Alzheimer’s have been identified in blood. The findings take researchers a step closer to knowing whether a blood test can be used to diagnose and measure progression of the Alzheimer’s disease.

Alzheimer’s Disease :: Curcumin helps in better performance for elderly in dementia, eat turmeric curry

Curcumin, the natural pigment that gives the spice turmeric its yellow colour, could slow mental decline in elderly people by 49 per cent, suggests a study of non-demented Asian people.